Also known as: NS2330
Tesofensine is a peptide classified as a triple monoamine reuptake inhibitor, primarily utilized in the category of fat loss and metabolic peptides. It was originally developed for the treatment of neurodegenerative diseases but has gained attention for its effects on weight management and metabolic processes. Tesofensine works by modulating neurotransmitter levels, which can influence appetite and energy expenditure.
Tesofensine operates by inhibiting the reuptake of three key neurotransmitters: serotonin, norepinephrine, and dopamine. This action increases the availability of these neurotransmitters in the synaptic cleft, which can lead to enhanced mood and reduced appetite. By targeting these pathways, Tesofensine may help regulate energy balance and promote fat loss.
Tesofensine is a peptide with notable applications in fat loss and metabolic regulation, primarily functioning as a triple monoamine reuptake inhibitor. Its ability to modulate neurotransmitter levels makes it a relevant subject of research in weight management and metabolic health.
Last updated: Feb 25, 2026